Literature DB >> 27556886

Semiparametric time-to-event modeling in the presence of a latent progression event.

John D Rice1, Alex Tsodikov1.   

Abstract

In cancer research, interest frequently centers on factors influencing a latent event that must precede a terminal event. In practice it is often impossible to observe the latent event precisely, making inference about this process difficult. To address this problem, we propose a joint model for the unobserved time to the latent and terminal events, with the two events linked by the baseline hazard. Covariates enter the model parametrically as linear combinations that multiply, respectively, the hazard for the latent event and the hazard for the terminal event conditional on the latent one. We derive the partial likelihood estimators for this problem assuming the latent event is observed, and propose a profile likelihood-based method for estimation when the latent event is unobserved. The baseline hazard in this case is estimated nonparametrically using the EM algorithm, which allows for closed-form Breslow-type estimators at each iteration, bringing improved computational efficiency and stability compared with maximizing the marginal likelihood directly. We present simulation studies to illustrate the finite-sample properties of the method; its use in practice is demonstrated in the analysis of a prostate cancer data set.
© 2016, The International Biometric Society.

Entities:  

Keywords:  Expectation-maximization algorithm; Semiparametric methods; Survival analysis

Mesh:

Year:  2016        PMID: 27556886      PMCID: PMC5325816          DOI: 10.1111/biom.12580

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  11 in total

1.  Discrete-time nonparametric estimation for semi-Markov models of chain-of-events data subject to interval censoring and truncation.

Authors:  M R Sternberg; G A Satten
Journal:  Biometrics       Date:  1999-06       Impact factor: 2.571

2.  Joint modeling of progression-free survival and death in advanced cancer clinical trials.

Authors:  David Dejardin; Emmanuel Lesaffre; Geert Verbeke
Journal:  Stat Med       Date:  2010-07-20       Impact factor: 2.373

3.  Semiparametric models: a generalized self-consistency approach.

Authors:  A Tsodikov
Journal:  J R Stat Soc Series B Stat Methodol       Date:  2003-08-01       Impact factor: 4.488

4.  Profile information matrix for nonlinear transformation models.

Authors:  A Tsodikov; G Garibotti
Journal:  Lifetime Data Anal       Date:  2007-03       Impact factor: 1.588

5.  Semiparametric regression analysis for time-to-event marked endpoints in cancer studies.

Authors:  Chen Hu; Alex Tsodikov
Journal:  Biostatistics       Date:  2013-12-29       Impact factor: 5.899

6.  The impact of heterogeneity in individual frailty on the dynamics of mortality.

Authors:  J W Vaupel; K G Manton; E Stallard
Journal:  Demography       Date:  1979-08

7.  Semiparametric estimation in a three-state duration-dependent Markov model from interval-censored observations with application to AIDS data.

Authors:  H Frydman
Journal:  Biometrics       Date:  1995-06       Impact factor: 2.571

8.  Joint modeling approach for semicompeting risks data with missing nonterminal event status.

Authors:  Chen Hu; Alex Tsodikov
Journal:  Lifetime Data Anal       Date:  2014-01-16       Impact factor: 1.588

9.  Discrete strategies of cancer post-treatment surveillance. Estimation and optimization problems.

Authors:  A D Tsodikov; B Asselain; A Fourque; T Hoang
Journal:  Biometrics       Date:  1995-06       Impact factor: 2.571

10.  Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma.

Authors:  C G Moertel; T R Fleming; J S Macdonald; D G Haller; J A Laurie; P J Goodman; J S Ungerleider; W A Emerson; D C Tormey; J H Glick
Journal:  N Engl J Med       Date:  1990-02-08       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.